603 related articles for article (PubMed ID: 21277261)
1. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
Ali SF
Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
[TBL] [Abstract][Full Text] [Related]
2. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
Procházková R; Andrýs C; Hubácková L; Krejsek J
Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
[TBL] [Abstract][Full Text] [Related]
3. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
Vasconcelos E; Figueiredo AC; Seghatchian J
Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
[TBL] [Abstract][Full Text] [Related]
4. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
[TBL] [Abstract][Full Text] [Related]
6. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of platelet quality obtained using conventional methods or from buffy-coat and stored at room temperature].
Dzieciatkowska A; Fuskiewicz M; Ziemba-Zółowska B; Sabliński J
Acta Haematol Pol; 1994; 25(2):135-43. PubMed ID: 8067184
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
9. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
[TBL] [Abstract][Full Text] [Related]
10. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
[TBL] [Abstract][Full Text] [Related]
11. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
[TBL] [Abstract][Full Text] [Related]
12. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
13. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
Seghatchian J
Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Impact-R for monitoring the platelet storage lesion.
Albanyan AM; Murphy MF; Harrison P
Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
[TBL] [Abstract][Full Text] [Related]
15. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
Sandgren P; Callaert M; Shanwell A; Gulliksson H
Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
[TBL] [Abstract][Full Text] [Related]
16. A critical comparison of platelet preparation methods.
Vassallo RR; Murphy S
Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
[TBL] [Abstract][Full Text] [Related]
17. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
Pietersz RN
Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
[TBL] [Abstract][Full Text] [Related]
18. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
Zeiler T; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
[TBL] [Abstract][Full Text] [Related]
19. [Quality of thrombocyte preparations from buffy coat or platelet-rich plasma].
Bux J; Müller K; Misterek J; Mueller-Eckhardt C
Beitr Infusionsther; 1990; 26():99-102. PubMed ID: 1703912
[TBL] [Abstract][Full Text] [Related]
20. Cytoskeletal reorganization after preparation of platelet concentrates, using the buffy coat method, and during their storage.
Estebanell E; Diaz-Ricart M; Lozano M; Mazzara R; Escolar G; Ordinas A
Haematologica; 1998 Feb; 83(2):112-7. PubMed ID: 9549921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
